期刊文献+

左旋多巴片制备工艺研究

Preparation Technology of Levodopa Tablets
在线阅读 下载PDF
导出
摘要 目的优化左旋多巴片制备工艺,提高产品质量。方法以溶出度、硬度、脆碎度为评价指标,采用L_(9)(3^(4))正交试验,筛选左旋多巴片处方,优化制备工艺。结果最优制备工艺为:微晶纤维素与预胶化淀粉质量比6∶1;羟丙甲纤维素70%乙醇溶液浓度3%;烘干温度65℃;整粒目数16目。结论采用优化工艺制备的左旋多巴片质量稳定,溶出度高。 OBJECTIVE To optimize the preparation technology of levodopa tablets and improve the product quality.METHODS The formulation of levodopa tablets was screened and the preparation process was optimized by L_(9)(3^(4))orthogonal test with dissolution,hardness and brittleness as evaluation indexes.RESULTS The optimal preparation process was as follows:the mass ratio of microcrystalline cellulose and pregelatinized starch was 6∶1;the concentration of hydroxypropyl methylcellulose was 70%,ethanol solution was 3%;the drying temperature was 65℃;the mesh number of granules was 16.CONCLUSION Levodopa tablets prepared by optimized technology have stable quality and high dissolution.
作者 秦建 QIN Jian(Jinghua Pharmaceutical Co.,Ltd.,Nantong 226000,China)
出处 《海峡药学》 2022年第12期16-18,共3页 Strait Pharmaceutical Journal
关键词 左旋多巴 正交试验 制备工艺 溶出度 Levodopa Orthogonal test Preparation technology Dissolution
作者简介 秦建,男(1974-)。学历:硕士。职称:主管药师。研究方向:药物制剂。
  • 相关文献

参考文献4

二级参考文献85

  • 1于香安,蔡怀友.用电子计算器求算片剂溶出度溶出参数的运算程序[J].中国药房,1995,6(4):21-22. 被引量:102
  • 2王刚,郑汭,谭玉燕,孙小康,周海燕,叶晓来,王瑛,王增,孙伯民,陈生弟.帕金森病疾病经济负担及相关因素的调查研究[J].中华神经科杂志,2006,39(5):336-337. 被引量:26
  • 3Zhang ZX, Roman GC, Hong Z, et al. Parkinson's disease in China: prevalence in Beijing, Xian, and Shanghai[J]. Lancet,2005,365: 595-597.
  • 4Dorsey ER, Constantinescu R, Thompson JP, et al. Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030[J]. Neurology,2007,68:384-386.
  • 5Schrag A, Dodel R, Spottke A, et al. Rate of ctinical progression in Parkinson's disease. A prospective study[J]. Mov Disord,2007,22: 938-945.
  • 6Hilker R, Schweitzer K, Coburger S, et al. Nonlinear progression of Parkinson disease as determined by serial positron emission tomographic imaging of striatal fluorodopa F 18 activity[J]. Arch Neurol,2005,62:378-382.
  • 7Fahn S, Oakes D, Shoulson i, et al. Levodopa and the progression of Parkinson's disease[J]. N Engl J Med,2004,351:2498-2508.
  • 8Olanow CW, Rascol O, Hauser R, et al. A double-blind, delayed- start trial of rasagiline in Parkinson's disease[J]. N Engl J Med, 2009,361 : 1268-1278.
  • 9Diamond SG, Markham CH, Hoehn MM, et al. Multi-center study of Parkinson mortality with early versus later dopa treatment[J]. Ann Neurol, 1987,22:8-12.
  • 10Jellinger KA. Neuropathology of sporadic Parkinson's disease: evaluation and changes of concepts[J]. Mov Disord,2012,27:8-30.

共引文献382

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部